feed,title,long_url,short_url
Benzinga,Aeglea Nosedives After Clinical Update On Investigational Candidate For Rare Metabolism Disease,https://benzinga.com/general/biotech/22/11/29907443/aeglea-shares-nosedives-after-clinical-update-on-investigational-candidate-for-rare-metabolism-di,https://bit.ly/3FfWaO6
